Shin Nippon Biomedical Laboratories, Ltd.
TSE:2395.T
1686 (JPY) • At close August 29, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 32,413.807 | 26,450.468 | 25,090.903 | 17,748.482 | 15,110.548 | 14,561.084 | 15,658.678 | 16,600.55 | 17,244.496 | 14,750.072 | 17,835.036 | 16,926.397 | 17,154.051 | 15,273.969 | 17,371.947 | 19,050.317 | 19,540.215 | 19,647.248 | 17,289.403 | 13,805.373 | 12,295.73 |
| Cost of Revenue
| 15,842.832 | 12,168 | 12,044.235 | 8,061.183 | 7,556.144 | 6,945.351 | 9,480.91 | 11,396.418 | 12,884.249 | 12,059.11 | 11,882.596 | 11,178.233 | 12,467.221 | 11,978.127 | 12,149.313 | 12,825.31 | 12,703.067 | 11,958.438 | 10,590.143 | 8,417.016 | 8,261.156 |
| Gross Profit
| 16,570.975 | 14,282.468 | 13,046.668 | 9,687.299 | 7,554.404 | 7,615.733 | 6,177.768 | 5,204.132 | 4,360.247 | 2,690.962 | 5,952.44 | 5,748.164 | 4,686.83 | 3,295.842 | 5,222.634 | 6,225.007 | 6,837.148 | 7,688.81 | 6,699.26 | 5,388.357 | 4,034.574 |
| Gross Profit Ratio
| 0.511 | 0.54 | 0.52 | 0.546 | 0.5 | 0.523 | 0.395 | 0.313 | 0.253 | 0.182 | 0.334 | 0.34 | 0.273 | 0.216 | 0.301 | 0.327 | 0.35 | 0.391 | 0.387 | 0.39 | 0.328 |
| Reseach & Development Expenses
| 2,217.685 | 1,741.195 | 683.065 | 425.075 | 392.238 | 400.853 | 339.818 | 518.395 | 600.603 | 815.632 | 739.355 | 747.079 | 577.233 | 979.126 | 699.322 | 699.75 | 652.61 | 706.083 | 1,003.587 | 729.513 | 755.135 |
| General & Administrative Expenses
| 2,248.491 | 1,931.321 | 1,348.22 | 1,000.617 | 835.079 | 859.319 | 953.431 | 906.253 | 1,017.474 | 1,145.863 | 1,073.095 | 1,070.631 | 1,060.924 | 1,258.038 | 1,248.733 | 1,213.527 | 1,382.688 | 1,356.061 | 1,292.604 | 975.569 | 893.625 |
| Selling & Marketing Expenses
| 1,839.622 | 6,186.331 | 6,467 | 4,546 | 4,158 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 11,368.074 | 8,117.652 | 6,894 | 4,908 | 4,482 | 859.319 | 953.431 | 906.253 | 1,017.474 | 1,145.863 | 1,073.095 | 1,070.631 | 1,060.924 | 1,258.038 | 1,248.733 | 1,213.527 | 1,382.688 | 1,356.061 | 1,292.604 | 975.569 | 893.625 |
| Other Expenses
| 0 | 261.371 | 224.361 | 158.607 | 150.624 | 4,127.302 | 97.451 | 38.916 | -69.841 | 168.492 | 162.37 | 170.515 | 194.956 | 486.244 | 389.787 | 542.117 | 229.534 | 176.084 | 29.962 | -20.272 | 14.565 |
| Operating Expenses
| 13,585.759 | 10,120.218 | 7,801.426 | 5,491.682 | 5,024.862 | 5,387.474 | 5,347.966 | 5,901.596 | 6,152.748 | 6,554.406 | 6,588.733 | 6,471.925 | 6,114.916 | 5,563.091 | 5,301.467 | 5,125.089 | 5,523.168 | 5,146.602 | 4,832.223 | 4,003.352 | 3,759.143 |
| Operating Income
| 2,985.216 | 4,162.359 | 5,245.233 | 4,195.609 | 2,529.534 | 2,228.251 | 829.795 | -697.471 | -1,792.506 | -3,863.449 | -636.3 | -723.769 | -1,428.091 | -3,048.924 | -843.656 | 343.832 | 463.937 | 1,585.633 | 1,125.776 | 772.202 | -328.969 |
| Operating Income Ratio
| 0.092 | 0.157 | 0.209 | 0.236 | 0.167 | 0.153 | 0.053 | -0.042 | -0.104 | -0.262 | -0.036 | -0.043 | -0.083 | -0.2 | -0.049 | 0.018 | 0.024 | 0.081 | 0.065 | 0.056 | -0.027 |
| Total Other Income Expenses Net
| 3,027.883 | 2,812.085 | 2,514.379 | 3,987.702 | 1,646.029 | 834.416 | 820.906 | -810.522 | 1,027.814 | 7,413.773 | 237.77 | 819.273 | 916.854 | 187.013 | -295.279 | 67.214 | -264.33 | -729.524 | -149.891 | -197.1 | -162.222 |
| Income Before Tax
| 6,013.099 | 6,974.444 | 7,759.612 | 8,183.311 | 4,175.563 | 3,062.667 | 1,650.701 | -1,507.993 | -764.692 | 3,550.324 | -398.53 | 95.504 | -511.237 | -2,861.911 | -1,138.935 | 411.046 | 199.607 | 856.109 | 975.885 | 575.102 | -491.191 |
| Income Before Tax Ratio
| 0.186 | 0.264 | 0.309 | 0.461 | 0.276 | 0.21 | 0.105 | -0.091 | -0.044 | 0.241 | -0.022 | 0.006 | -0.03 | -0.187 | -0.066 | 0.022 | 0.01 | 0.044 | 0.056 | 0.042 | -0.04 |
| Income Tax Expense
| 1,148.509 | 1,456.736 | 1,708.903 | 1,016.205 | 497.792 | 414.541 | -308.088 | 2,013.233 | 127.781 | 903.419 | 992.416 | 857.597 | 651.425 | 443.124 | 314.403 | -116.575 | 412.7 | 264.141 | 433.639 | 309.391 | -17.005 |
| Net Income
| 4,924.847 | 5,531.261 | 6,060.057 | 7,127.629 | 3,661.855 | 2,550.379 | 1,950.307 | -3,555.948 | -915.938 | 2,646.136 | -1,385.737 | -754.991 | -1,152.876 | -3,304.109 | -1,442.021 | 534.529 | -205.549 | 599.874 | 543.769 | 267.412 | -472.444 |
| Net Income Ratio
| 0.152 | 0.209 | 0.242 | 0.402 | 0.242 | 0.175 | 0.125 | -0.214 | -0.053 | 0.179 | -0.078 | -0.045 | -0.067 | -0.216 | -0.083 | 0.028 | -0.011 | 0.031 | 0.031 | 0.019 | -0.038 |
| EPS
| 118.3 | 132.86 | 145.57 | 171.21 | 87.96 | 61.26 | 46.85 | -85.41 | -22.18 | 66.52 | -34.84 | -20.12 | -33.57 | -96.21 | -43.26 | 16.14 | -6.03 | 17.46 | 15.83 | 8.28 | -14.63 |
| EPS Diluted
| 118.3 | 132.86 | 145.57 | 171.21 | 87.96 | 61.26 | 46.85 | -85.41 | -22.18 | 66.52 | -34.84 | -20.12 | -33.57 | -96.21 | -43.26 | 16.14 | -6.03 | 17.46 | 15.83 | 8.28 | -14.63 |
| EBITDA
| 8,826.937 | 8,981.213 | 9,485.146 | 9,487.39 | 5,548.108 | 4,526.832 | 3,390.11 | 338.823 | 1,159.219 | 5,446.726 | 1,283.242 | 1,721.367 | 1,165.785 | -959.749 | 967.899 | 2,692.19 | 2,314.782 | 2,927.283 | 2,458.15 | 1,672.993 | 495 |
| EBITDA Ratio
| 0.272 | 0.34 | 0.378 | 0.535 | 0.367 | 0.311 | 0.217 | 0.02 | 0.067 | 0.369 | 0.072 | 0.102 | 0.068 | -0.063 | 0.056 | 0.141 | 0.118 | 0.149 | 0.142 | 0.121 | 0.04 |